Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131940) titled 'Amisulpride for the Treatment of Postoperative Nausea and Vomiting in Obese Patients Undergoing Metabolic Surgery' on Sept. 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Nanning People's Hospital
Condition:
Postoperative nausea and vomiting in obese patients after metabolic surgery
Intervention:
Amisulpride Group:Amisulpride injection 10mg iv
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-10
Target Sample Size: Amisulpride Group:66;Control Group:66;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...